Stockholm, Sweden-based image enhancement developer ContextVision is establishing clinical and commercial partnerships to expand into the data quality market.
The new strategy will integrate machine-aided interpretation and organ-specific acquisition intelligence to improve physiological quantification from imaging modalities and enable the implementation of digital biomarkers, the company said.
The move is in response to the rapidly advancing digital transformation in healthcare and a strategic evolution of its image quality business, which today is focuses on enhancing medical image quality, according to ContextVision.
